Literature DB >> 17274988

ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation.

Joffrey Degoutin1, Marc Vigny, Jean Y Gouzi.   

Abstract

Activation of the neuronal receptor tyrosine kinase ALK (anaplastic lymphoma kinase) promoted the neuron-like differentiation of PC12 cells through specific activation of the ERK MAP-kinase pathway. However, the nature of primary signaling events initiated is still poorly documented. Here, we established that Shc and FRS2 adaptors were recruited and phosphorylated following antibody-based ALK activation. We further demonstrated that Shc was recruited to the consensus phosphotyrosine site NPTpY(1507) and FRS2 was likely recruited to a novel non-orthodox phosphotyrosine site within ALK. Finally, we characterized a functional role for Shc and likely FRS2 in ALK-dependant MAP-kinase activation and neuronal differentiation of PC12 cells. These findings hence open attractive perspectives concerning specific characteristics of ALK in the control of the mechanisms driving neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17274988     DOI: 10.1016/j.febslet.2007.01.039

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Structural basis for the recognition of nucleophosmin-anaplastic lymphoma kinase oncoprotein by the phosphotyrosine binding domain of Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target-2.

Authors:  Seizo Koshiba; Hua Li; Yoko Motoda; Tadashi Tomizawa; Takuma Kasai; Naoya Tochio; Takashi Yabuki; Takushi Harada; Satoru Watanabe; Akiko Tanaka; Mikako Shirouzu; Takanori Kigawa; Tadashi Yamamoto; Shigeyuki Yokoyama
Journal:  J Struct Funct Genomics       Date:  2010-05-08

2.  Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors.

Authors:  Guolin Zhang; Hannah Scarborough; Jihye Kim; Andrii I Rozhok; Yian Ann Chen; Xiaohui Zhang; Lanxi Song; Yun Bai; Bin Fang; Richard Z Liu; John Koomen; Aik Choon Tan; James Degregori; Eric B Haura
Journal:  Sci Signal       Date:  2016-10-18       Impact factor: 8.192

3.  Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.

Authors:  Marius Grzelinski; Florian Steinberg; Tobias Martens; Frank Czubayko; Katrin Lamszus; Achim Aigner
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

Review 4.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

5.  Neurotrophin and FGF Signaling Adapter Proteins, FRS2 and FRS3, Regulate Dentate Granule Cell Maturation and Excitatory Synaptogenesis.

Authors:  Sayan Nandi; Karina Alviña; Pablo J Lituma; Pablo E Castillo; Jean M Hébert
Journal:  Neuroscience       Date:  2017-11-16       Impact factor: 3.590

6.  Structural insights into FRS2α PTB domain recognition by neurotrophin receptor TrkB.

Authors:  Lei Zeng; Miklos Kuti; Shiraz Mujtaba; Ming-Ming Zhou
Journal:  Proteins       Date:  2014-07

7.  Frs2α enhances fibroblast growth factor-mediated survival and differentiation in lens development.

Authors:  Bhavani P Madakashira; Daniel A Kobrinski; Andrew D Hancher; Elizabeth C Arneman; Brad D Wagner; Fen Wang; Hailey Shin; Frank J Lovicu; Lixing W Reneker; Michael L Robinson
Journal:  Development       Date:  2012-11-07       Impact factor: 6.868

8.  The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning.

Authors:  Jean Y Gouzi; Anastasios Moressis; James A Walker; Anthi A Apostolopoulou; Ruth H Palmer; André Bernards; Efthimios M C Skoulakis
Journal:  PLoS Genet       Date:  2011-09-15       Impact factor: 5.917

9.  Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.

Authors:  Kamaraj Sattu; Falko Hochgräfe; Jianmin Wu; Ganesh Umapathy; Christina Schönherr; Kristina Ruuth; Damini Chand; Barbara Witek; James Fuchs; Pui-Kai Li; Fredrik Hugosson; Roger J Daly; Ruth H Palmer; Bengt Hallberg
Journal:  FEBS J       Date:  2013-08-22       Impact factor: 5.542

Review 10.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.